Valore202020212022202320242025TTMSpese di vendita, generali e amministrative6.9 B8.2 B8.52 B7.33 B7.76 B8.23 B8.23 BRicerca e sviluppo1.35 B1.74 B1.75 B1.5 B1.58 B1.6 B1.6 BReddito operativo4.23 B7.46 B8.69 B5.2 B4.86 B4.69 B4.69 BProventi non operativi, Totale583 M881 M-456 M-54 M184 M-431 M-431 MOneri finanziari, al netto degli interessi capitalizzati275 M238 M211 M286 M278 M265 M265 MProventi non operativi, esclusi gli oneri finanziari269 M187 M-441 M-165 M-38 M-474 M-474 MEntrate/uscite straordinarie39 M456 M-226 M-175 M-56 M-222 M-222 MUtile al lordo delle imposte4.5 B7.6 B8.29 B5.04 B4.65 B4.23 B4.23 BQuota di utile———————Imposte849 M1.25 B1.08 B823 M747 M633 M633 MInteressi di minoranza———————Altri proventi/oneri al netto delle imposte———————Utile netto al lordo delle attività cessate3.06 B5.84 B7.21 B4.22 B3.9 B3.6 B3.61 BAttività cessate589 M589 M0543 M014 M—Utile netto3.65 B6.43 B7.21 B4.76 B3.9 B3.61 B3.61 BRegolazione della diluizione1 M78 M20 M000—Dividendi privilegiati136 M164 M106 M21 M00—Utile netto diluito attribuibile agli azionisti ordinari3.51 B6.35 B7.12 B4.74 B3.9 B3.61 B3.61 BUtile base per azione (EPS base)4.978.779.86.445.335.075.07Utile diluito per azione (EPS diluito)4.898.619.666.385.295.055.05Numero medio di azioni ordinarie in circolazione706.2 M714.6 M725.1 M736.5 M731 M712.7 M2.86 BAzioni diluite in circolazione718.7 M736.8 M737.1 M743.1 M737.2 M716.1 M2.87 BEBITDA4.82 B8.14 B9.39 B5.76 B5.28 B4.84 B4.88 BEBIT3.04 B5.97 B7.17 B3.59 B2.93 B2.4 B1.16 BCosto del fatturato9.81 B11.5 B12.52 B9.86 B9.67 B10.04 B10.04 BAltri costi del venduto———————Ammortamento e svalutazione (liquidità)1.77 B2.17 B2.22 B2.17 B2.35 B2.45 B3.72 B
Danaher Corporation
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000.